A relatively new treatment addresses "the root cause of anxiety, depression, PTSD, and Long COVID symptoms," according to the company Stella Global's website, which promotes its use.
Psilocybin, the psychoactive compound in “magic mushrooms,” could be administered to help treat post-traumatic stress ...
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, ...
As the first Schedule 1 psychedelic medicine to go through the FDA review process – in other words, based on a drug ... PTSD, along with their loved ones, who have not seen any new treatment ...
Emory is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with psychotherapy.
The research tracked the psychological responses of more than 650 survivors from the festival. Two-thirds of these were under ...
This has allowed authorised prescribers to administer MDMA and psilocybin for the treatment of PTSD and treatment-resistant depression outside of clinical trials, respectively. The ANZJP study found ...
Alzamend Neuro announced the completion of a device designed by Tesla Dynamic Coils, to monitor lithium levels in the brain, which will help researchers identify therapeutic target doses for a range ...
Psychiatrist Ted Cassidy said the drugs needed ... out [from their treatment] and now they're symptom-free, which is a really dramatic, unexpected result with things like PTSD," he said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results